Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

PLLA injections can cause hair loss and skin issues.

Phospholipase C-δ1 is crucial for normal hair development.

GLABRA2 gene controls root-hair growth by regulating phospholipid signaling.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Phospholipase A2 enzymes play key roles in skin health and disease.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

The MLPH gene is not linked to seasonal hair loss in Rhodesian Ridgeback dogs.

A genetic mutation in the LIPH gene causes hair loss and growth defects.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

GLPLS and LPP are variants of lichen planus.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

A PKP1 gene mutation causes skin fragility and hair loss in Chesapeake Bay retriever puppies.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

PDLLA filler can improve hair thickness and shine by reducing age-related hair decline.

Poly-D,L-lactic acid boosts hair growth in aged skin by activating hair follicle stem cells.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Long-Acting Platelet Rich Plasma therapy can effectively reduce hair shedding, thicken hair, and promote new growth in women with pattern hair loss.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

pCLCA2 protein may help maintain skin structure and function.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.